PUVA combination therapy.
Various adjunctive treatments are now frequently used in combination with PUVA therapy with the aims of limiting adverse effects, improving efficacy and decreasing the cost of treatment. In the management of psoriasis, PUVA plus retinoids, PUVA plus methotrexate and PUVA plus UVB phototherapy are the most frequently used combinations. PUVA plus topical corticosteroids and PUVA plus anthralin are also efficacious but adverse effects and poor acceptance by patients are limiting factors. Combinations of PUVA plus nitrogen mustard and ionizing radiation are used in mycosis fungoides to treat tumors and residual disease in secluded sites. In the management of photodermatoses with PUVA therapy, prednisone is often required to prevent exacerbation of disease. A combination of prednisone and PUVA therapy can also be useful in lichen planus and atopic eczema. The selection of a suitable combination treatment, will depend upon the preferences of the clinician, the disease being treated, and the characteristics of the patient.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000875:Anthralin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D011701:PUVA Therapy; D010789:Phototherapy; D011565:Psoriasis / Q000188:drug therapy* / Q000628:therapy; D012176:Retinoids / Q000627:therapeutic use; D012871:Skin Diseases / Q000628:therapy; D014467:Ultraviolet Therapy
D000305:Adrenal Cortex Hormones; D012176:Retinoids; D000875:Anthralin; D008727:Methotrexate